相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis
Francesco Campanaro et al.
AUTOIMMUNITY REVIEWS (2021)
Role of Janus Kinase inhibitors in rheumatoid arthritis treatment
Virginia Reddy et al.
CURRENT OPINION IN RHEUMATOLOGY (2021)
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Inhibition of JAK/STAT signaling in rheumatologic disorders: The expanding spectrum
Thomas El Jammal et al.
JOINT BONE SPINE (2020)
Comorbidities associated with psoriatic arthritis: Review and update
Lourdes M. Perez-Chada et al.
CLINICAL IMMUNOLOGY (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
Douglas J. Veale et al.
RHEUMATOLOGY (2019)
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis
Katie Bechman et al.
RHEUMATOLOGY (2019)
JAK inhibitors for the treatment of autoimmune and inflammatory diseases
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2019)
Psoriatic arthritis 1 The pathogenesis of psoriatic arthritis
Douglas J. Veale et al.
LANCET (2018)
Tofacitinib for the treatment of psoriasis and psoriatic arthritis
Anna Berekmeri et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
Philip Mease et al.
LANCET (2018)
The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review
Mette Brandt Eriksen et al.
JOURNAL OF THE MEDICAL LIBRARY ASSOCIATION (2018)
Psoriatic Arthritis
Christopher T. Ritchlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
P. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Dafna Gladman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease et al.
ARTHRITIS CARE & RESEARCH (2017)
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee et al.
DRUGS (2017)
Recognizing and managing comorbidities in psoriatic arthritis
Alexis Ogdie et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Incremental Effects of Comorbidity on Quality of Life in Patients with Psoriatic Arthritis
Janice A. Husted et al.
JOURNAL OF RHEUMATOLOGY (2013)
Psoriatic Arthritis: Phenotypic Variance and Nosology
Lihi Eder et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life
Konstantinos Kotsis et al.
ARTHRITIS CARE & RESEARCH (2012)
Janus kinases in immune cell signaling
Kamran Ghoreschi et al.
IMMUNOLOGICAL REVIEWS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
DD Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
分享论文
